phosphodiesterase inhibitors with combined inotropic and vasodilatory action include amrinone , which is no longer in widespread use due to its pronounced side-effects , milrinone , which is much better tolerated and has shown promising results in recent large-scale trials , and sulmazole which has been withdrawn due to toxic effects in rodents .
C0002697
amrinone
C0128513
milrinone